期刊文献+

女性人乳头瘤病毒感染、疗效与性伴关系的相关性研究 被引量:1

The correlation study of papilloma virus infection,curative effect and sexual partner relationship of the female
下载PDF
导出
摘要 目的:初步探讨女方发现感染人乳头瘤病毒,其性伴HPV感染对女性治疗疗效的影响。方法:门诊体检发现人乳头瘤病毒的女性患者,对其性伴进行人乳头瘤病毒检测;而后将性伴无HPV感染的女性患者分为A组(68例),配偶有HPV感染女性患者分为B组(68例)、C组(68例),三组进行相同治疗,但A、C组患者禁止性生活或采取避孕套性生活,B组正常、非避孕套性生活。结果:女方体检发现人乳头瘤病毒感染的358例患者,其性伴HPV感染为296例;A组和C组疗效明显优于B组(P<0.05),有统计学差异;A组与C组疗效相似(P>0.05),没有统计学差异。结论:女性人乳头瘤病毒感染患者,其性伴HPV感染率高,且女性的治疗疗效与性伴感染与否有密切关系。 Objectives: To study the situation of women infected with human papilloma virus and the efficacy of the treatment when their sexual partners were infected. Method: We selected women who were found infected with human papilloma virus in the clinic and gave their sexual partners papilloma virus detection. The female patients were divided into three groups,group A( 68 cases) whose sexual partners were not infected by HPV,group B( 68 cases) and C( 68 cases) whose sexual partners were infected by HPV. All the patients were treated by the same way. The patients in group A,C were prohibited to have sex with their partners; the patients in the group B had normal sex life with their partners even without condom. Result: The number of woman who were found infected by human papilloma virus was 358. The number of their sexual partners who were infected by human papilloma was296; the curative effect of Group A and group C was better than that of group B( P〈 0. 05),with statistically significant difference. The curative effect of Group A and group C was similar,with no statistical differences( P〈 0. 05). Conclusion: For women who were infected by HPV,the HPV infection rate of their partner is high. And the treatment efficacy is closely related with the infection situation of their sexual partners.
出处 《中国性科学》 2015年第3期42-44,共3页 Chinese Journal of Human Sexuality
关键词 HPV 疗效 相关性研究 HPV Efficacy Correlation study
  • 相关文献

参考文献1

二级参考文献22

  • 1Schottenfeld D, Bcebehe-diminer JL. Advances in cancer epidemlology: understanding causal mechanisms and the evidence for implementing interventions [J]. Annu Rev Public Health, 2005, 26:37-60.
  • 2Bulk S, Berkhof J, Bulkmans NW, et al. Preferential risk of HPV16 for squamous cell carcinoma and of HPV 18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands[J]. Br J Cancer, 2006, 94(1): 171-175.
  • 3Chen W, Zhang X, Molijn A, et al. Human papillomavirus type-distribution in cervical cancer in China: the impor- tance of HPV 16 and 18[J]. Cancer Causes Control, 2009, 20(9):1705-1713.
  • 4Altekruse SF, Lacey JV, Brinton LA,et al. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adcnocarcinoma and squamous cell carcinoma: Northeastern United States [J]. Am J Obstet Gynecol, 2007, 188(3):657-663.
  • 5Bulkmans NW, Berkhof J, Bulk S, et al. High-risk HPV type-specific clearance rates in cervical screening[J]. Br J Cancer, 2007, 96(9):1419-1424.
  • 6Song SH, Lee JK, Oh M J, et al. Risk factors for the pro- gression or persistence of untreated mild dysplasia of the uterine cervix[J]. Int J Gynecol Cancer, 2006, 16(4):1608- 1613.
  • 7Nunez-Troeonis J, Delgado M, Gonzalez J, et al. Preva- lence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area[J]. Invest Clin, 2009, 50(2):203-212.
  • 8Wu QJ, Guo M, Lu ZM, et al. Detection of human papillo-mavims-16 in ovarian malignancy [J]. Br J Cancer,2003, 89(4):672-675.
  • 9Atalay F, Taskiran C, Taner MZ, et al. Detection of human papillomavirus DNA and genotyping in patients with epithe- lial ovarian carcinmna [J]. J Obstet Gynaecol Res, 2007, 33(6): 823-828.
  • 10Sutton BC, Allen RA, Moore WE, et al. Distribution of hu- man papillomavirus genotypes in invasive squamous carci- noma of the vulva[J]. Mod Pathol, 2008, 21(3):345-354.

共引文献11

同被引文献9

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部